Stock Market Live June 29, 2026: S&P 500 (SPY) Soaring in Holiday-Shortened Week

Retail

Chris Lange

Chris Lange is a writer for 24/7 Wall St., based in Houston. He has covered financial markets over the past decade with an emphasis on healthcare, tech, and IPOs. During this time, he has published thousands of articles with insightful analysis across these complex fields. Currently, Lange's focus is on military and geopolitical topics.

Lange's work has been quoted or mentioned in Forbes, The New York Times, Business Insider, USA Today, MSN, Yahoo, The Verge, Vice, The Intelligencer, Quartz, Nasdaq, The Motley Fool, Fox Business, International Business Times, The Street, Seeking Alpha, Barron’s, Benzinga, and many other major publications.

A graduate of Southwestern University in Georgetown, Texas, Lange majored in business with a particular focus on investments. He has previous experience in the banking industry and startups.

Chris Lange | Oct 1, 2020 at 9:47 AM EDT

Why the Bed Bath & Beyond Turnaround Finally Has Come True

Bed Bath & Beyond reported better than expected fiscal second-quarter financial results before the markets opened on Thursday.

Chris Lange | Sep 30, 2020 at 3:51 PM EDT

Did Palantir’s Market Debut Live Up to the Hype?

Sofftware platform maker Palantir Technologies came public Wednesday through a direct listing that valued the company at about $22 billion.

Chris Lange | Sep 30, 2020 at 1:33 PM EDT

Why Analysts Are Cautiously Optimistic About Micron After Earnings

Although investors were disappointed with the Micron Technology quarterly results, analysts looked further out and were fairly positive.

Chris Lange | Sep 30, 2020 at 11:39 AM EDT

Why Pizza Giants Will Keep Thriving After the Pandemic

The name of the game for restaurants during the government-mandated COVID-19 lockdowns has been delivery, and nobody does that better…

Chris Lange | Sep 30, 2020 at 9:22 AM EDT

2 Big Positive Developments in the COVID-19 Vaccine Race

Moderna and Regeneron Pharmaceuticals each announced positive news late on Tuesday about their respective COVID-19 vaccine trials.

Chris Lange | Sep 29, 2020 at 1:17 PM EDT

Beyond Meat’s Distribution Expansion With Walmart Is Only Natural

Beyond Meat shares hit a multiyear high on Tuesday after the company announced that it would expand its long-standing relationship…

Chris Lange | Sep 29, 2020 at 11:40 AM EDT

Why Aptorum Stock Absolutely Took Off on Tuesday

Aptorum shares absolutely exploded on Tuesday after the company announced that it would be launching a subsidiary focused on novel…

Chris Lange | Sep 29, 2020 at 10:12 AM EDT

McCormick Announces Stock Split and Earnings Beat

McCormick reported better than expected second-quarter financial results and a 2-for-1 stock split before the markets opened on Tuesday.

Chris Lange | Sep 28, 2020 at 3:08 PM EDT

Genfit and Lab Corp Partner Up For NASH Liver Test

Genfit SA (NASDAQ: GNFT) shot up on Monday after the company announced an agreement with Lab Corporation of America Holdings…

Chris Lange | Sep 28, 2020 at 11:10 AM EDT

Eiger BioPharmaceuticals COVID-19 Study Fails to Live Up to Expectations

Eiger BioPharmaceuticals has announced disappointing results from a study of Peginterferon Lambda-1a (Lambda) in outpatients with mild and uncomplicated COVID-19.